155 related articles for article (PubMed ID: 28526854)
1. Induction of senescence in primary glioblastoma cells by serum and TGFβ.
Kumar R; Gont A; Perkins TJ; Hanson JEL; Lorimer IAJ
Sci Rep; 2017 May; 7(1):2156. PubMed ID: 28526854
[TBL] [Abstract][Full Text] [Related]
2. Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1.
Li Y; Hu J; Guan F; Song L; Fan R; Zhu H; Hu X; Shen E; Yang B
Oncol Rep; 2013 May; 29(5):1805-10. PubMed ID: 23468063
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.
Birch JL; Coull BJ; Spender LC; Watt C; Willison A; Syed N; Chalmers AJ; Hossain-Ibrahim MK; Inman GJ
Cell Signal; 2020 Aug; 72():109638. PubMed ID: 32320860
[TBL] [Abstract][Full Text] [Related]
4. IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine 'bystander senescence'.
Hubackova S; Krejcikova K; Bartek J; Hodny Z
Aging (Albany NY); 2012 Dec; 4(12):932-51. PubMed ID: 23385065
[TBL] [Abstract][Full Text] [Related]
5. IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2.
Hubackova S; Kucerova A; Michlits G; Kyjacova L; Reinis M; Korolov O; Bartek J; Hodny Z
Oncogene; 2016 Mar; 35(10):1236-49. PubMed ID: 25982278
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the TGFβ pathway in the regulation of α5 β1 integrins by caveolin-1 in human glioblastoma.
Cosset EC; Godet J; Entz-Werlé N; Guérin E; Guenot D; Froelich S; Bonnet D; Pinel S; Plenat F; Chastagner P; Dontenwill M; Martin S
Int J Cancer; 2012 Aug; 131(3):601-11. PubMed ID: 21901744
[TBL] [Abstract][Full Text] [Related]
7. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
[TBL] [Abstract][Full Text] [Related]
8. Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells-EGFRvIII Appears as a Weak Oncogene.
Włodarczyk A; Tręda C; Rutkowska A; Grot D; Dobrewa W; Kierasińska A; Węgierska M; Wasiak T; Strózik T; Rieske P; Stoczyńska-Fidelus E
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292985
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP
Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.
Xu XL; Kapoun AM
J Transl Med; 2009 Feb; 7():12. PubMed ID: 19192267
[TBL] [Abstract][Full Text] [Related]
11. Anthocyanidins inhibit epithelial-mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells.
Ouanouki A; Lamy S; Annabi B
Mol Carcinog; 2017 Mar; 56(3):1088-1099. PubMed ID: 27649384
[TBL] [Abstract][Full Text] [Related]
12. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β pathway activity in glioblastoma.
Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic analysis reveals that BMP4 sensitizes glioblastoma tumor-initiating cells to mechanical cues.
Hughes JH; Ewy JM; Chen J; Wong SY; Tharp KM; Stahl A; Kumar S
Matrix Biol; 2020 Jan; 85-86():112-127. PubMed ID: 31189077
[TBL] [Abstract][Full Text] [Related]
15. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.
Jones KA; Gilder AS; Lam MS; Du N; Banki MA; Merati A; Pizzo DP; VandenBerg SR; Gonias SL
Neuro Oncol; 2016 May; 18(5):667-78. PubMed ID: 26420897
[TBL] [Abstract][Full Text] [Related]
16. Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
Fuentes-Fayos AC; G-García ME; Pérez-Gómez JM; Montero-Hidalgo AJ; Martín-Colom J; Doval-Rosa C; Blanco-Acevedo C; Torres E; Toledano-Delgado Á; Sánchez-Sánchez R; Peralbo-Santaella E; Ortega-Salas RM; Jiménez-Vacas JM; Tena-Sempere M; López M; Castaño JP; Gahete MD; Solivera J; Luque RM
EBioMedicine; 2023 Apr; 90():104484. PubMed ID: 36907105
[TBL] [Abstract][Full Text] [Related]
17. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
[TBL] [Abstract][Full Text] [Related]
18. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma Cells Do Not Affect Axitinib-Dependent Senescence of HUVECs in a Transwell Coculture Model.
Merolle M; Mongiardi MP; Piras M; Levi A; Falchetti ML
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098270
[TBL] [Abstract][Full Text] [Related]
20. A way to understand idiopathic senescence and apoptosis in primary glioblastoma cells - possible approaches to circumvent these phenomena.
Janik K; Treda C; Wlodarczyk A; Peciak J; Rosiak K; Zieba J; Grot D; Rutkowska A; Pawlowska R; Och W; Rieske P; Stoczynska-Fidelus E
BMC Cancer; 2019 Sep; 19(1):923. PubMed ID: 31521143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
